Skip to main content
. 2016 Dec 1;1(1):250–265. doi: 10.1089/trgh.2016.0031

Table 1.

Identification and Validation Logic

Transgender Medicare Beneficiaries
  No. identified No. validated % validated
ICD-9 diagnosis codes 302.50, 302.51, 302.52, 302.53, 302.6, 302.85a 4098 3658 89.26
Validation method
ICD-9 302 series diagnosis code and 1 or more of the following:
  No. validated % validated
More than 1 claim with an ICD-9 302 series diagnosis code in 2013 2706 66.03
1 or more claims with an ICD-9 302 series diagnosis code in 2012 1577 38.48
1 or more claims with an ICD-9 302 series diagnosis code in 2014 1937 47.26
1 or more claims with an ICD-9 259.9 diagnosis code in 2013 568 13.86
1 or more prescriptions for a sex hormone in 2013 2005 48.89
Principal diagnosis code is from ICD-9 302 series 1736 42.36
1 or more CC 45 modifier 167 4.08
1 or more KX modifier 26 0.6

Each validation step is calculated independently from all other validation steps, and “% validated” is calculated from the total number of transgender beneficiaries identified (N=4098).

a

Referred to as the 302 series for the purposes of this table.

ICD-9, International Classification of Diseases ninth edition.